Agoracom Blog

Tetra Bio-Pharma $TBP.ca to engage in co-development and distribution partnership with major healthcare specialty distributor

Posted by AGORACOM-JC at 8:19 AM on Wednesday, September 20th, 2017

Tbp large new

  • Announced that it has signed a letter of intent (LOI) with a major player of the healthcare specialty industry
  • Privately-owned partner has a pan-Canadian distribution network that reaches up to 7000 specialized healthcare professionals
  • First product will be launched in Q1 2018 with subsequent products already in development for the remainder of 2018
  • Tetra and its partner will be tapping into the overall Over-The-Counter topical analgesics market of more than $300 million in sales in Canada, with the US market reaching over $2.9 billion, according to an IMS analysis

OTTAWA, ONTARIO–(Sept. 20, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that it has signed a letter of intent (LOI) with a major player of the healthcare specialty industry.

This privately-owned partner, which asked to remain unnamed for the time being, has a pan-Canadian distribution network that reaches up to 7000 specialized healthcare professionals. Through their distribution channel, they have access to over 3000 specialized healthcare businesses in Canada and already work with a worldwide network of partners, including the USA.

Tetra and its partner are working together to develop a new line of products, leveraging Tetra’s clinical and product development expertise. The first product will be launched in Q1 2018 with subsequent products already in development for the remainder of 2018. Tetra and its partner will be tapping into the overall Over-The-Counter (OTC) topical analgesics market of more than $300 million in sales in Canada, with the US market reaching over $2.9 billion, according to an IMS analysis. Both companies are expecting to grab a share if the specialized OTC topical analgesics market in a short period of time and could see sales generated from this distribution channel reaching $3 million for Canada in the 1st year. Since the initial launch phase will be focused on the Canadian market, further guidance will be provided as Tetra’s partner gets ready to launch in the US.

« We’re excited to enter this specialized market as there is a significant need for our clinical expertise in product development. This partnership opens a new distribution channel for our pharmaceutical retail division not only in Canada, but also worldwide through their active partners in the US and Europe. Tetra remains committed and is actively developing partnerships to generate a significant revenue stream. This partnership demonstrates our team’s focus and dedication in accelerating our commercialization strategy towards selling a specialized line of products in our pharmaceutical retail business, » comments Bernard Fortier, CEO of Tetra Bio-Pharma.

About Tetra Bio-Pharma:

Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra has three core expertise: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based drugs.

More information at: www.tetrabiopharma.com.

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Anne-Sophie Courtois
Vice-President Marketing & Communication
1 (514) 360-8040 Ext. 210
Anne-sophie.courtois@tetrabiopharma.com
www.tetrabiopharma.com

INTERVIEW: HPQ Silicon $HPQ.ca Discusses Importance Of Operational “Mini Model” Of Planned 200 tonnes Per Annum Pilot Plant

Posted by AGORACOM-JC at 4:19 PM on Tuesday, September 19th, 2017

$GR.ca Great Atlantic Receives Diamond Drilling Permit Keymet Precious – Base Metal Property Bathurst, New Brunswick

Posted by Er at 9:28 AM on Tuesday, September 19th, 2017

 

 

  • Located 20 kilometres northwest of Bathurst
  • Multiple pathfinder minerals located ( gold, silver, zinc, lead and / or copper occurrences )
  • 500 metre drill program to test multiple base metal and silver bearing vein occurrences

Vancouver, British Columbia (FSCwire)GREAT ATLANTIC RESOURCES CORP. (TSXV.GR) (the “Company” or “Great Atlantic”) is pleased to announce it has received a diamond drilling permit from the New Brunswick Dept. of Energy and Mines for its Keymet Precious – Base Metal Property, located in northeast New Brunswick. The Company is planning drilling beginning in mid-September in the northwest region of the property. The Keymet property, located approximately 20 kilometres northwest of Bathurst, hosts multiple gold, silver, zinc, lead and / or copper occurrences including the Keymet deposit, site of the historic Keymet Mine. Drilling will further test an area of reported zinc, lead, copper and silver bearing vein(s) including 2015 Great Atlantic drill intersections (16.7 % zinc and 152 g/t silver over 1.8 meter core length and 8.7% zinc over 4.28 meter core length) and a near-by gold bearing zone discovered by the Company in a 2015 trench (1.1 g/t gold over 4.9 meters in channel sampling).

 

To view the graphic in its original size, please click here

 

The drilling program is planned for the northwest region of the Keymet Property, a priority area for the Company. The program will be a minimum of 500 metres. Multiple base metal and silver bearing vein occurrences are reported in this region, including the historic Keymet Mine which operated during the 1950s. The drilling program will further test one of these vein occurrences, referred to as the Elmtree 12 vein occurrences. Gold bearing boulders and gold bearing zones in trench bedrock are also documented in this region of the property. The drilling program will test one such gold zone.

 

Historic Keymet Mine (1950s)

To view the graphic in its original size, please click here

 

The Elmtree 12 base metal and silver bearing vein occurrence is located approximately 1.4 kilometres northwest of the historic Keymet Mine. Closed-spaced 1980s diamond drill holes (Brunswick Mining and Smelting and Aurtec Inc.) intersected near-surface mineralized veins in this area. A 0.88 metre core length interval from a 1981 drill hole was reported to grade 7.72% Cu, 11.36% Zn and 13.6 ounces per ton Ag. A 1.22 metre core length sample from a near-by 1989 drill hole was reported to assay 16.4% Cu, 10.11% Zn and 31.0 ounces per ton Ag. The true width of these intersections is unknown. These drill intersections are within 50 metre vertical depth. During 2015, Great Atlantic conducted trenching in the area of these reported 1980s drill holes. One trench exposed a northwest striking mineralized vein approximately above the reported 1980s drill intersections. A 0.5 metre channel samples across the vein returned 1.52% zinc, 1.94% copper and 308 g/t silver.

 

During 2015 Great Atlantic drilled two holes (Ky-15-3 and Ky-15-4) in the area of the 2015 trench and the 1980s holes. These holes were also collared within a zone of gold bearing silicified sedimentary boulders previously discovered by the Company (boulder assays reported up to 51 grams per tonne Au.). The zone of gold-bearing boulders extends west of these two holes in the reported up-ice glacial direction. Both holes intersected base metal and silver bearing veins and local gold mineralization.

 

 

Zinc, copper and silver bearing vein in 2015 Trench at Elmtree 12 Vein Occurrence

To view the graphic in its original size, please click here

 

Both Ky-15-3 and Ky-15-4 were drilled from the same set-up to the northeast (050 degree azimuth) approximately under the previous 2015 trench and from the opposite direction as the reported 1980s holes. Ky-15-3 was drilled at a 45 degree angle and intersected sphalerite – rich veins at 60.80 – 62.60 metres (returning 16.68% zinc, 1.11% copper and 152.0 g/t silver over a 1.80 metre core length). Ky-15-4 was drilled at a 60 degree dip on the same azimuth to intersect the veins deeper. Multiple sphalerite bearing veins were intersected in this hole at 90.07 – 94.35 metres (returning 8.68% zinc and 44.8 g/t silver Ag over 4.28 metre core length), approximately 35 metres vertically under the main vein intersected in Ky-15-3. Hole Ky-15-3 intersected a gold bearing interval, with a sample at 30.10 – 32.20 meters (2.1 meter core length) returning 3.28 g/t gold. The true width of these initial 2015 drill intersections is unknown at this time.

 

Drilling is planned during September 2017 on either side of holes Ky-15-3 and Ky-15-4 testing the continuation of the zinc, copper and silver bearing veins along strike and testing the continuation of the gold bearing zone intersected in Ky-15-3.

 

Drilling is also planned during the September program under a gold bearing zone exposed during a 2015 trench southwest of holes Ky-15-3 and Ky-15-4. Channel samples from a zone of altered sediments returned 1.11 g/t gold over a 4.9 metre total length. The channel samples were orientated east-west parallel to the trench direction. The orientation of this gold bearing zone has not been determined. This gold bearing zone is approximately 80 metres southwest of the collars of holes Ky-15-3 and Ky-15-4.

 

Zinc (sphalerite) – bearing carbonate vein in Ky-15-4.

To view the graphic in its original size, please click here

 

Access to the property is excellent with paved roads transecting the property, including a provincial highway. The property covers an area of approximately 3,400 hectares.

 

Readers are warned that historical records referred to in this News Release have been examined but not verified by a qualified person. Further work is required to verify that historical assays referred to in this News Release are accurate.

 

David Martin, P.Geo., a Qualified Person as defined by NI 43-101, is responsible for the technical information contained in this News Release.

 

About Great Atlantic Resources Corp.: Great Atlantic Resources Corp. is a Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Tungsten and Gold.

 

On Behalf of the board of directors

 

“Lorne Mann

 

This press release includes certain statements that may be deemed “forward-looking statements”. All statements in this release, other than statements of historical facts, that address future exploration drilling, exploration activities and events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include exploitation and exploration successes, continued availability of financing, and general economic, market or business conditions.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Great Atlantic Resource Corp

888 Dunsmuir Street – Suite 888, Vancouver, B.C., V6C 3K4

PyroGenesis $PYR.ca Announces Commencement of Advanced Second Phase Lab Scale Testing with HPQ Silicon Resources $HPQ.ca

Posted by AGORACOM-JC at 9:12 AM on Tuesday, September 19th, 2017

Pyr header 1

  • Informed its client, HPQ Silicon Resources Inc that the Gen 2 PUREVAP Quartz Reduction Reactor (referred to herein as: “Gen 2 PUREVAP“), a 1/250 scale model of the planned 200 metric tonne (MT) per year pilot plant (the “Pilot Plant”),
  • Will be operational in the coming weeks, and that an advanced, second phase, lab scale testing program is about to commence.

MONTREAL, QUEBEC–(September 19, 2017) – PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX VENTURE:PYR)(OTCQB:PYRNF), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma waste-to-energy systems and plasma torch products, is pleased to announce today that, further to its press release dated on May 4, 2017, it has informed its client, HPQ Silicon Resources Inc (“HPQ”), that the Gen 2 PUREVAP Quartz Reduction Reactor (“QRR“) (referred to herein as: “Gen 2 PUREVAP“), a 1/250 scale model of the planned 200 metric tonne (MT) per year pilot plant (the “Pilot Plant”), will be operational in the coming weeks, and that an advanced, second phase, lab scale testing program is about to commence.

As previously announced, the first generation lab scale PUREVAP QRR (referred to herein as: “Gen 1 PUREVAP“) was built to prove that Silicon Metal (Si) could be produced directly from quartz in just one step, for the solar panel industry.

The Gen 2 PUREVAP will focus on Process Refinement, Characterization, Metallurgical Testing and purity improvements using this new semi-continuous feed 1/250 scale model.

Based on Gen 1 PUREVAP results, PyroGenesis completed the detailed engineering and design of the Pilot Plant, including substantial process modifications, and as a result, this Gen 2 PUREVAP is an upgraded version of the Gen 1 PUREVAP that will be a true 1/250 scale replica of the planned larger pilot plant (“Gen 3 PUREVAP“). The Gen 2 PUREVAP is currently undergoing final manufacturing, assembly and testing, and will be operational during the first weeks of October 2017.

The start of this new metallurgical testing program using the Gen 2 PUREVAP represents major de-risking of the Pilot Plant program as the Gen 2 PUREVAP will:

  1. Allow for specific process design improvements and modifications derived from Gen 1 PUREVAP test work to be implemented and perfected;
  2. Produce larger Silicon Metal (Si) samples to test improvements to the purification process;
  3. Allow an intermediate step in scaling up to the Pilot Plant, thereby mitigating the scaling up risk;
  4. Allow for the following milestones to be reached sooner than originally planned:
    • Producing larger Si samples for testing by potential purchasers;
    • Allow HPQ and PyroGenesis to test the electrical parameters of the High Purity Si;
    • Produce enough material to send samples to solar industry participants; and
    • Provide data to demonstrate the economics of PUREVAP™ technology.

“We are happy to see this new phase of the project. This new reactor will allow us to produce larger quantities of silicon and validate the process for the pilot phase,” said Pierre Carabin, Chief Technology Officer of PyroGenesis.

The next key milestone is to produce quantities of solar grade silicon for testing of its electrical characteristics, sending material to industry participants and finalize Pilot plant design en route to commercialization.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2008 certified, and have been ISO certified since 1997. PyroGenesis is a publicly-traded Canadian company on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace (Ticker Symbol: PYRNF). For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTC Markets Group Inc. accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

Rodayna Kafal
VP, Investor Relations and Communications
(514) 937-0002
ir@pyrogenesis.com
rkafal@pyrogenesis.com

PUREVAP(TM) Pilot Plant Testing Starting Early With Commissioning of $HPQ.ca 1/250 Scale Pilot Equipment

Posted by AGORACOM-JC at 7:40 AM on Tuesday, September 19th, 2017

Hpq large

  • Advanced, second stage bench testing program is about to commence
  • Gen 2 PUREVAPtm Quartz Reduction Reactor (“QRR”) reactor, 1/250 scale model of the planned 200 tonnes per annum (tpa) Pilot Plant will be operational in the coming weeks

MONTREAL, QUEBEC–(Sept. 19, 2017) – HPQ Silicon Resources Inc (“HPQ”) (TSX VENTURE:HPQ)(FRANKFURT:UGE)(OTC PINK:URAGF) is pleased to advise shareholders that an advanced, second stage bench testing program is about to commence. PyroGenesis Canada Inc (PyroGenesis) has informed HPQ that the Gen 2 PUREVAPtm Quartz Reduction Reactor (“QRR”) reactor, 1/250 scale model of the planned 200 tonnes per annum (tpa) Pilot Plant will be operational in the coming weeks.

Bernard J. Tourillon, Chairman and CEO of HPQ Silicon stated, “The design and construction of the Gen 2 PUREVAPtm QRR is another exciting step toward commercialization and is a result of the collaborative efforts of PyroGenesis and HPQ. Building on our success to date the Gen 2 PUREVAPtm QRR will allow for further refinements to the silicon purification and testing of the numerous process improvements now planned for the Pilot Plant. This will greatly de-risk our project and provide valuable information sooner as we continue to make the process adjustments needed to produce Solar Grade Silicon Metal.”

GEN 1 PUREVAPtm QRR REACTOR: SUCCESSFUL AND NOW BEING RETIRED

The first generation batch lab scale PUREVAPtm QRR (now referred to as Gen 1 PUREVAPtm) was built to prove the concept that quartz could be transformed in one step into Silicon Metal (Si), for the solar panel industry. A series of tests using the Gen 1 PUREVAPtm were ordered (September 2, 2016 PR) to generate key technical data required for the design of the 200 tpa pilot plant capable of producing Solar Grade Si (SoG Si). The Gen 1 PUREVAPtm process succeeded, demonstrating significant impurity removal, in one step, transforming low purity SiO2 (Quartz) into 3N+ Purity Si (99.97% Si) (May 16, 2017 PR, January 26, 2017 PR, November 29, 2016 PR, November 2, 2016 PR and September 29, 2016 PR). This product exceeds the highest purity level of the Metallurgical Grade Silicon Metal (Mg Si) industry, a US$5.5 billion dollar per year industry1.

1 Source CRU, 2018 MG Si demand projected at 2,5 M tonnes, 2018 prices US$2,200 per tonne (Ferroglobe)

Our next key milestone is to produce quantities of solar grade silicon for testing of its electrical characteristics, sending material to industry participants and finalize Pilot plant design en route to commercialization. CEO Bernard Tourillon commented, “Our Gen 1 PUREVAPtm was a great success and we believe the reactor will eventually make its way to a science and engineering hall of fame. It has currently reached its maximum operational efficiencies and nothing more could be gained by additional tests.”

GEN 2 PUREVAPtm QRR REACTOR PRESENTS MAJOR DE-RISKING MILESTONES

The Gen 2 Purevap™ QRR will focus on Process Refinement, Characterization, Metallurgical Testing and purity improvements using the new semi-continuous feed 1/250 scale pilot-plant (May 4, 2017, PR).

Based on Gen 1 PUREVAPtm results, PyroGenesis completed the detailed engineering and design of the 200 tpa pilot plant, including substantial process modifications. Gen 2 PUREVAPtm therefore is an upgraded version of the Gen 1 Purevaptm that will be a true 1/250 scale replica of the planned larger pilot plant (Gen 3 PUREVAPtm). The Gen 2 PUREVAPtm is undergoing final manufacturing, assembly and testing and will be operational during the first weeks of October 2017.

The start of this new metallurgical testing program using The Gen 2 PUREVAPtm represents major de-risking of the Pilot Plant program for the following reasons:

  • Gen 2 will allow specific process design improvements and modifications derived from Gen 1 PUREVAPtm test work to be implemented and perfected;
  • The Gen 2 produces larger silicon Metal (Si) samples to test improvements to the purification process;
  • Gen 2 allows an intermediate step in scaling up to the Pilot Plant, mitigating that scaling up risk;
  • Gen 2 will allow the following Milestones to be reached sooner than originally planned;
    • Producing larger Si samples for testing by potential purchasers;
    • Allows HPQ and Pyrogenesis to test the electrical parameters of the High Purity Si;
    • Produce enough material to send samples to Solar industry participants;
    • Provide data to demonstrate the economics of PUREVAP™ QRR.

PYROGENESIS CEO REMARKS

We are pleased to join HPQ in announcing both reaching this new milestone and commencing the second stage testing program,” said P. Peter Pascali, President and CEO of PyroGenesis. “I also wish to commend the team, both at PyroGenesis and HPQ, for having persevered through the many challenges to date and for all the discoveries they made along the way (the ability to transform low purity Quartz into 3N+ Silicon Metal in one step at lab scale not being the least of them). As we have said in the past, it will not be a straight line to success, but given the results to date we are more confident then ever before that we will have a commercial success. What level of success, is yet to be determined. As in all projects, delays will occur, but I firmly believe we are on the right track to have a significant impact in the high purity silicon and solar markets.

UPDATE ON SILICON METAL PURITY TESTING

Further to our June 23, 2017 press release, the company continued to work with PyroGenesis and a number of specialized laboratories on silicon analysis protocols. Specifically, efforts focus on analytical procedures, certification, and analysis turn around time. We are working with our partners to resolve the analytical bottlenecks.

Results will be reported in a comprehensive report on the proof of concept and phase one process characterization and metallurgical testing programs, being prepared by PyroGenesis.

This Press Release Is Available On The Company’s CEO Verified Discussion Forum, A Moderated Social Media Platform That Enables Civilized Discussion and Q&A Between Management and Shareholders.

About HPQ Silicon

HPQ Silicon Resources Inc is a TSX-V listed resource company planning to become a vertically integrated and diversified Metallurgical Grade and Solar Grade Silicon Metal producer.

Our business model is focused on developing a disruptive one step High Purity and Solar Grade Silicon Metal manufacturing process (patent pending). HPQ plans to generate high yield returns and significant free cash flow within a relatively short time line. The process will have a greatly decreased carbon footprint, energy footprint, and will eliminate the use of the toxic chemical reagents and by products now in use by the current solar silicon production technologies, which fundamentally date from designs made in the mid 1900’s.

Disclaimers:

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Shares outstanding: 170,003,173

HPQ Silicon Resources Inc.
Bernard J. Tourillon
Chairman and CEO
(514) 907-1011

HPQ Silicon Resources Inc.
Patrick Levasseur
President and COO
(514) 262-9239
www.HPQSilicon.com

Namaste $N.ca Added to Newly Created CSE25 Index #Vapes #Vaping #CSE25

Posted by AGORACOM-JC at 4:17 PM on Monday, September 18th, 2017

Nlogo

  • New index comprised of the securities of the largest companies trading on the exchange
  • CSE25 Index is a subgroup of the CSE Composite Index

Toronto, Ontario–(September 18, 2017) – The Canadian Securities Exchange (“CSE”) is pleased to announce the introduction of a new index comprised of the securities of the largest companies trading on the exchange.

The CSE25 Index is a subgroup of the CSE Composite Index. The composite index launched in 2015 and includes almost half of the exchange’s listed companies and covers over 75% of the trading activity on the exchange. The new index includes the top twenty-five securities by market capitalization contained in the composite index. These companies account for over 50% of the weighting in the larger index and are typically stocks that attract considerable trading volume.

Richard Carleton, CEO, observed that “as the exchange has grown rapidly in terms of trading volumes and market capitalization it is appropriate that we give market participants a benchmark that monitors the performance of our largest and most liquid issues. As the ‘exchange for entrepreneurs’ we are proud of their success in the Canadian capital markets.”

Trading volumes on the CSE have been exceptionally robust in 2016 and 2017. The turnover of the entire market measured by the value of trading divided by the total market cap has averaged 6.6% per month in the year to date, which represents a level of market activity unrivalled in the Canadian exchange space.

A complete list of the constituent securities of the CSE25 Index appears below.

Symbol Security Name CSE 25
Weighting
LHS Liberty Health Sciences Inc. 14.31%
TRST CannTrust Holdings Inc. 13.00%
URB.A Urbana Corporation A NV 6.25%
AHG Alternate Health Corp. 5.69%
MARI Maricann Group Inc 5.13%
CRZ CannaRoyalty Corp. 4.90%
BCC The Canadian Bioceutical Corporation 4.11%
MDM Marapharm Ventures Inc 3.96%
URG Oriental Non-Ferrous Resources Development Corp. 3.68%
GLH Golden Leaf Holdings Ltd. 3.56%
XMG MGX Minerals Inc. 3.13%
FLT Drone Delivery Canada Corp. 2.99%
THC THC Biomed Intl Ltd 2.88%
ISOL Isodiol International Inc. 2.82%
IN InMed Pharmaceuticals Inc. 2.76%
BLO Cannabix Technologies Inc. 2.54%
N Namaste Technologies Inc. 2.22%
IAN iAnthus Capital Holdings Inc. 2.22%
VGW Valens Groworks Corp. 2.22%
MTA Metalla Royalty and Streaming Ltd. 2.15%
SNA Star Navigation Systems Group Ltd. 2.02%
LDS Lifestyle Delivery Systems Inc 1.95%
MYM MYM Nutraceuticals Inc. 1.91%
MRM Micromem Technologies Inc. 1.81%
RSS RESAAS Services Inc. 1.80%

 

About the CSE

The Canadian Securities Exchange is home to more than 300 uniquely listed issues covering a broad range of industry sectors. The exchange provides trade execution, smart routing, risk management, compliance and market information services for Canadian listed instruments.

Recognized as an exchange by the Ontario Securities Commission in 2004, the CSE is designed to facilitate the capital formation process for public companies through a streamlined approach to company regulation that emphasizes disclosure and the provision of efficient secondary market trading services for investors.

For more information please visit www.thecse.com and our blog at blog.thecse.com.

Rob Cook
Senior Vice President, Market Development
Rob.Cook@thecse.com
416-367-7349

betterU Education Corporation $BTRU.ca Launches a Corporate Training Program With the ‘Central Bank of India’

Posted by AGORACOM-JC at 9:12 AM on Monday, September 18th, 2017

Betteru large

  • Launched their corporate training initiatives to support employee training across the variety of industries, jobs and categories to support corporate India
  • Selected by the Central Bank of India to provide instructor led leadership training in Mumbai for all their Assistant General Managers
  • Training program completed with high reviews from the bank and their positive feedback will help advance betterU’s efforts across the country

OTTAWA, Sept. 18, 2017 — betterU Education Corp. (the “Corporation” or “betterU”), is pleased to announce that they have launched their corporate training initiatives to support employee training across the variety of industries, jobs and categories to support corporate India.

betterU’s corporate training was selected by the Central Bank of India to provide instructor led leadership training in Mumbai for all their Assistant General Managers. The training program completed with high reviews from the bank and their positive feedback will help advance betterU’s efforts across the country. “It was a great privilege to have been selected by the Central Bank of India and we are excited about the results of the training and their positive feedback about the quality of our work.  We are looking forward to our going work with the bank as we continue to build our relationship,” said Sameer Vatsa, Country Head of India for betterU Education Corp.

Skills development is a critical part of any corporate environment and with advancing technology and globalization corporations must continually work to ensure their employees receive upgrading skills to stay competitive and innovative. betterU has built a corporate learning ecosystem that provides access to thousands of skills development programs from some of the world’s leading educators. Today’s corporate HR departments must source, negotiate and validate multiple training partners to support their wide range of training across their many verticals of operations. By leveraging the breadth and depth of programs available through betterU, corporations can offer innovative, leading programs across all their needs including for soft skills, leadership, management, IT / Technology, office and more. As a master training partner, betterU can collaborate with an organization to assemble a full service self-paced, Instructor-led and/or blended national programs that can support the requirements of an entire organization.

About betterU

betterU, a global education marketplace, aims to provide access to quality education from around the world to foster growth and opportunity to those who want to better their lives. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ‘education-to employment’ ecosystem. betterU’s offerings can be categorized into four broad functions: to compliment school programs with flexible KG-12 programs preparing children for next stage of education, to foster an exceptional educational environment by providing befitting skills that lead to a better career, to bridge the gap between one’s existing education and prospective job requirement by training them and lastly, to connect the end user to various job opportunities.

www.betterU.ca and www.betterU.in

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release may contain forward-looking statements and information, which may involve risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Factors that might cause a difference include, but are not limited to, competitive developments, risks associated with betterU’s growth, the state of the financial markets, regulatory risks and other factors. There can be no assurance or guarantees that any statements of forward-looking information contained in this release will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral statements containing forward-looking information are based on the estimates and opinions of management on the dates they are made and expressly qualified in their entirety by this notice. Unless otherwise required by applicable securities laws, betterU disclaims any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise. Readers should not place undue reliance on any statements of forward-looking information that speak only as of the date of this release. Further information on betterU’s public filings, including their most recent audited consolidated financial statements, are available at www.sedar.com.

For further information, please visit  http://www.betteru.ca/investor-overview/

Investor contact:

Investor Relations
1-613-695-4100 Ext. 233
Email: ir@betteru.ca

PyroGenesis $PYR.ca Additive Confirms Production, and Orders, for Both Ti-6Al-4V Grade 23 & Grade 5 MIM Cut

Posted by AGORACOM-JC at 9:04 AM on Monday, September 18th, 2017

Pyr header 1

  • Company now confirms that process can, in fact, make titanium MIM cut Grade 23 powder in commercial quantities
  • Already received orders for samples of both Grade 5 and, most notably, Grade 23 Ti-6AL-4V MIM cut powders. 

MONTREAL, QUEBEC–(Sept. 18, 2017) – PyroGenesis Additive, a division of PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX VENTURE:PYR)(OTCQB:PYRNF), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma waste-to-energy systems and plasma torch products, is pleased to announce today that, further to its press release dated August 14, 2017, wherein it was announced that the Company had developed a new plasma-based atomization process to produce metal powders for 3D printers, specifically the MIM cut titanium (Ti-6Al-4V) powder Grade 5 (which for the purposes herein, we define as small fine metal powders, that can be used by metal 3D printers, typically in the 5um-25um size range), and wherein it was also announced that it seemed that the same process might make titanium MIM cut Grade 23, the Company now confirms that this process can, in fact, make titanium MIM cut Grade 23 powder in commercial quantities. Further to this, the Company is also pleased to announce that it has already received orders for samples of both Grade 5 and, most notably, Grade 23 Ti-6AL-4V MIM cut powders.

Mr. P. Peter Pascali, President and CEO of PyroGenesis, provides an overview of today’s announcement in the following Q&A format:

Q. What is the attraction of MIM cut powders?

A. The use of a MIM cut powder allows improved surface finish and increased definition of the parts. MIM cut refers to a powder size traditionally intended for use in the Metal Injection Molding industry, hence the phrase “MIM”. We also use this term to describe this same size cut (i.e., the finest powder size produced by plasma atomization, typically below 25um), and which we are seeing a potentially explosive demand for by metal 3D printers. The press has most recently noted the increased interest in using this fine powder by 3D printer manufactures such as Desktop Metal, Markforged and 3DEO. These new printing technologies hold the promise of much higher throughput and reduced costs compared to mainstream printers.

Of note, and where PyroGenesis Additive has applicability, is that the metal 3D printer demands for this MIM cut cannot be serviced by the powders which traditionally were used by Metal Injection Molding, as they are not pure enough.

The MIM cut powder of Ti-6Al-4V has traditionally only been available, in commercial quantities, as Grade 5. Given PyroGenesis Additive’s new plasma-based process, as described in its September 12, 2017 news release, it is now able to address this market by producing extremely narrow size distributions, at significantly higher production rates, with higher yields (i.e. little to no waste), and at much lower operating costs for both Grade 5 and Grade 23 in commercial quantities.

To the best of our knowledge, we know of no other company that offers commercial quantities of Ti-6Al-4V Grade 23 MIM cut.

Once again, PyroGenesis Additive is inventing, and innovating, thereby enabling 3D printers to reach new levels.

Q. What is the difference between Grade 5 and Grade 23?

A. The primary difference between the two is oxygen content, with Grade 23 having less oxygen content than Grade 5 (i.e. maximum oxygen content of 0.13% vs 0.20%). Since MIM cut powders are smaller, there is a tendency to have increased oxygen content due to more exposed surface area.1 Therefore, it is very difficult, in this particle range to have low oxygen content which is sometimes preferred.

Q. Why is it a challenge to make Grade 23? 

A. There are two challenges in making Grade 23 MIM cut powder: 1) quality and 2) quantity.

First, quality: because of its small size and relatively high surface area, the powder tends to pick up oxygen easily. By carefully controlling the operating environment of the plasma reactor, it is possible to minimize the oxygen pickup and, consequently, the oxygen content of the final powder.

Second, quantity: plasma processes have traditionally been designed to produce relatively large powders. By allowing to shift the particle size distribution to smaller sizes, the new PyroGenesis process maximizes the amount of powder available in the MIM cut range.

Q. Can you give us an update on sample orders and shipments?

A. To date, PyroGenesis Additive has received six (6) unique sample orders, including one sample order for our Grade 23 and Grade 5 MIM cut. Of these sample orders, we have currently shipped four (4).

Q. So, in conclusion, when will this success translate into more substantial orders?

A. It is important to put these sample orders in context. We never expected to receive any sample orders during the ramp-up phase. It is, as you can imagine, very difficult to project any sales from these sample orders. However, I think it is safe to say that given the amount of interest, the timing, and the type of clients we are seeing, we can expect that some future long-term contracts might be in the very near future. If that is true, one can well imagine that the impact on the Company could be so significant that whether that happens in a week, a month, or six (6) months, the difference in timing is a drop in the bucket when compared to the commercial implications.

I can say however, that these sample orders have translated into company visits; both to our facilities and to theirs… and remember this is all during ramp-up.

As previously announced, PyroGenesis Additive will be exhibiting at this year’s TCT show in Birmingham, England (Sept 26 – 28). The TCT Show is one of the world’s leading events dedicated to 3D printing, Additive Manufacturing and product development as over 250 exhibitors are showcased to more than 7,000 attendees. We invite those who will be attending the show to stop by our booth# C61 and speak with our sales team: Mr. Massimo Dattilo, VP, PyroGenesis Additive, and Mr. Alex Pascali, Sales Manager, PyroGenesis Additive.

Separately, PyroGenesis announces today that it will be presenting at The MicroCap Conference on October 5, 2017, at the Essex House in New York City. The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. Mr. Pascali will provide an overview of the Company’s business, during a live presentation and has scheduled several one-on-one meetings with investors who are registered to attend the conference. This event is exclusive to portfolio managers, analysts, and private investors.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2008 certified, and have been ISO certified since 1997. PyroGenesis is a publicly-traded Canadian company on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace (Ticker Symbol: PYRNF). For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTC Markets Group Inc. accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

1 “Titanium Powder Metallurgy: Science Technology and Application”, Ma Quian and Francis H. Froes editors, Elsevier, 2015, 2015, p.340.

Rodayna Kafal
VP, Investor Relations and Communications
(514) 937-0002
ir@pyrogenesis.com or rkafal@pyrogenesis.com

Tetra Bio-Pharma $TBP.ca getting ready to file a clinical trial application to initiate phase 3 clinical trial on terminal cancer patients in the coming weeks

Posted by AGORACOM-JC at 8:17 AM on Monday, September 18th, 2017

Tbp large new

  • Announced that it will be filing a clinical trial application in the coming weeks to therapeutic products directorate 
  • Purpose to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients
  • With this filing, Tetra expects to be on time with its previously announced schedule with the development of PPP001

OTTAWA, ONTARIO–(Sept. 18, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announces that it will be filing a clinical trial application (CTA) in the coming weeks to therapeutic products directorate (TPD) to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients. With this filing, Tetra expects to be on time with its previously announced schedule with the development of PPP001. The corporation worked with physicians of Sante Cannabis to design a clinical trial that would demonstrate the safety and efficacy of PPP001 in terminal cancer patients. In addition, as part of the clinical trial, Tetra will collect the pharmacoeconomics evidence required from provincial insurers in order to support the reimbursement of the first cannabis prescription drug.

A significant percentage of patients placed on a cannabis treatment suffer from side effects that are not tolerable. This can lead to patients stopping a potentially effective therapy. As part of its early phase clinical research, Tetra developed dosing strategies to minimize moderate and severe side effects in patients. This dosing strategy was developed in healthy volunteers over the last few months and has shown to be effective in reducing the severity of the side effects and preventing certain serious ones. This allows TBP to initiate its Phase 3 trial based on clinical data proposing a more tolerable approach to consuming smoked cannabis and to assess PPP001 in terminal cancer patients. This is a significant step in the development of a safe, tolerable and effective new drug for the management of chronic pain in terminal cancer patients with co-morbidities.

This will be the first Phase 3 clinical trial studying the therapeutic benefits of a smoked dried cannabis prescription drug in terminal cancer patients. Due to the status of cannabis under the Controlled Drugs and Substances Act in Canada, over the last four months the corporation developed procedures and methods that would both satisfy the Narcotic Controls Regulations and ensure the protection of patients consuming the cannabis. The corporation is confident that these procedures will be well received by Health Canada as they ensure compliance with both the Food and Drug Act and Controlled Drugs and Substances Act.

Tetra also reports that it has restructured its investors and public relation functions to integrate them with the marketing and communication functions. Mr. Edward Miller is leaving the Corporation effective as of today. We want to thank Mr. Miller for the work he has done for the Corporation over the last months and wish him all the success he deserves for his new professional projects.

About PPP001:

PPP001 aims to be the first smokable marihuana for advanced cancer pain under prescription. It is a dried cannabis pellet designed to be smoked in an inhalation device specifically developed for this product.

About Tetra Bio-Pharma:

Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra has three core expertise: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based drugs.

More information at: www.tetrabiopharma.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Source: Tetra Bio-Pharma

Tetra Bio-Pharma Inc.
Anne-Sophie Courtois
Vice- President Marketing & Communication
(514) 360 8040 Ext. 210
Anne-sophie.courtois@tetrabiopharma.com
www.tetrabiopharma.com

AGORACOM welcomes Augusta Industries $AAO.ca providing world leading solutions to the oil and gas and structural health monitoring industries

Posted by AGORACOM-JC at 4:58 PM on Friday, September 15th, 2017

Augustalarge

FOX-TEK

A wholly owned subsidiary of
Augusta Industries Inc.

  • Engaged in the development, design, manufacture and supply of systems using fiber optic sensors, related monitoring instruments, and software
  • Clients include Enbridge and The Pembina Institute
  • Marcon’s major clients include Saudi Arabia-Sabic Services (Refining and Petrochemical), Bahrain National Gas Co, Bahrain Petroleum, Qatar Petroleum, Qatar Gas, Qatar Petrochemical, Gulf of Suez Petroleum, Agiba Petroleum and Burullus Gas Co
  • Provides support engineering services related to planning, training, on-site installation, and data interpretation and reporting.

 

CLIENTS INCLUDE


FOX-TEK’s systems serve the needs of the oil and gas, power generation, chemical, mining, and civil structure market sectors, worldwide.

  • Systems can be configured to operate continuously or on an inspection basis.
  • They can also be monitored remotely

Oil And Gas

 

Mining

  • Sensors measure displacement to add value in the areas of critical operations, safety, environmental protection, improved maintenance, and extended lifetime.
  • Systems are built on proven components and know-how in the areas of telecommunications based fiber optics, electronics and optics, and control and signal processing software.

Marcon International

  • Involved in the industrial supply of equipment and parts procuring for its clients which are principally clients in the oil and gas industry and United States government agencies such as the Department of Defense, Department of the Interior, Department of Homeland Security and Department of Agriculture.
  • Provides procurement and support services to existing and new projects worldwide in the energy sector. Initially the company had focused on providing services in the energy sector but moved on to government contracts and government services.

Marcon has two subsidiaries, Marcon USA and Marcon UK, to help enhance and support its logistic and sales operations

  • Servicing the energy sector and a number of US Government entities. Marcon’s principal business is the sale and distribution of industrial machinery and equipment such as cranes, derricks, diesel engines, conveyor systems, oil refining machines, packing machinery, industrial pumps and welding machinery.
  • In addition to departments and agencies of the U.S. Government, Marcon’s major clients include Saudi Arabia-Sabic Services (Refining and Petrochemical), Bahrain National Gas Co, Bahrain Petroleum, Qatar Petroleum, Qatar Gas, Qatar Petrochemical, Gulf of Suez Petroleum, Agiba Petroleum and Burullus Gas Co.